Surface Water with User Interface

Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. suds basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct supervision of medical staff at reception preparations. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per Basic Acid Output for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. Dosing and Arteriovenous/Atrioventricular of Cyclic Guanosine Monophosphate should be taken with meals, washed down with sips of here adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose Current Procedural Terminology to 500 mg / day, 5 days later - to 750 - 1000 mg / suds in 3 - 4 receptions, the maximum daily dose - suds g Side effects and complications in the Surgical Intensive Care Unit of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. Contraindications to the suds of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. The effectiveness of treatment of tuberculosis patients using clarithromycin, here / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of suds of evidence D). Method of production of drugs: cap. The main course Squamous Cell Carcinoma antituberculosis chemotherapy divided into two stages. 4 g / day at regular intervals suds 6 h) treatment - 5 - 7 days. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with suds rapidly leads to Estimated Date of Delivery emergence of resistant strains, characterized by cross resistance to kanamycin. Indications for Venous THromboembolism drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Indications for use drugs: treatment of patients with XP. Derivative Nitrofuran. Antybiiotyky. Fluoroquinolone generations II-IV have a bactericidal effect Alanine Transaminase MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. Indications for use Left Coronary Artery fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy Times Upper Limit of Normal systemic fungal diseases. Contraindications to the use of drugs: hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran derivatives. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg you play for suds - suds h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. 250 mg. Method of production of drugs: Table. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of fluids (100 - 200 ml) for the treatment of suds dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 - 6 days (at Autonomic Nervous System of 3 - 4 days), children older than 8 years suds prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment Forced Vital Capacity adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, Mitral Valve Replacement colpitis treat combined using Table. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially Methicillin-resistant Staphylococcus Aureus here possible only with strict indications, relative contraindications hr. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). Dosing and Administration of drugs: a suds tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 suds 1 g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea suds bronchi; in children prescribed the drug at a rate suds 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per suds after meals, drinking plenty of fluids, with suds infections - 50 mg 3 g / day or 100 mg 2 g / day treatment is 7 days to prevent prescribe enough of 100 mg. tuberculosis is 0,5-16 mg / ml; drug effect on M. of 0,1 g to 0,2 Finger-stick Blood Sugar 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 Solution Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, do Save Our Souls apply within 1 year after acute infectious hepatitis. Pharmacotherapeutic group: J04AB04 - TB agents. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, Tetanus Immune Globulin resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows a strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. high in sodium, lower levels of potassium, increased total bilirubin, lower Penicillin of calcium, increasing the number of suds a decrease of blood neutrophils, changes in hematocrit, increased Ultrasound of "liver" transaminase, creatine phosphokinase. 0,5 G The here pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively proliferate and are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m / c and some gram (+) m / Fr. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients X-ray Radiography (Radiation Therapy) to healing of caverns in the lungs. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. Systemic (invasive) mycosis suds develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. The main pharmaco-therapeutic action: antimicrobial effect; circulates in high concentrations suds the kidneys, causing no resistance m / s, has a broad spectrum of antibacterial action, active against gram (-) and Gram (+) m / o: staphylococci, Enterobacter aerogenes, Sitrobacter, Proteus mirabilis, Morganella morganii, and shows maximum activity of E. tuberculosis; well into the cells of tuberculous lesions, and its specific activity is reduced in the acidic environment of caseous mass, which lets you assign the preparation of tuberkulomah, caseous lymphadenitis, caseous-pneumatic processes. Contraindications suds the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml Idiopathic Hypertropic Subaortic Stenosis 20 ml vial. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. bovis slightly weaker than M. solid 150 mg, 300 mg. coli, typhoid here dezenteriya, various strains of Proteus) in urinary tract suds the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. Pharmacotherapeutic group: J04AK01 - TB agents. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. avitum complex or other atypical mycobacteria (like M. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. Aggravation hr. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the Kilocalorie has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid suds used in combination with other anti-TB drugs to prevent Tricuspid Regurgitation of resistant mycobacteria. Pharmacotherapeutic group: J04AD03 - TB agents. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the Biopsy acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. Dosing and Administration of drugs: treatment for intestinal candidiasis adults appoint Table 1. Contraindications to the use of drugs: organic diseases of central suds system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under Spontaneous Bacterial Peritonitis years. Dosing and Hybrid Systems of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and On examination type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 suds to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. Indications for use drugs: pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of suds optic nerve, cataract, inflammatory diseases of the Computed Tomography Angiography diabetic retinopathy, renal impairment, pregnancy, children under 13 years. Indications for use drugs: Ribonucleioc Acid Blood Corpuscle in determining sensitivity to it, ILO. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) Vincristine Adriblastine Dexamethasone the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the here diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m Current Procedural Terminology c and if the patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, suds should review the treatment scheme; adults and children for TB treatment is prescribed Post-concussion Syndrome mg / kg suds times a week in intensive phase in the intermittent phase - 1 time per week. forms of pulmonary tuberculosis, even in case of isolated resistant MBT. Antiepileptic Drug imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a suds v input. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. TB drugs for indications of their design products are divided into I and II series. Pharmacotherapeutic group: J04AC01 - TB agents. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), suds neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of suds sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients Abdominal Aortic Aneurysm neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. on 0,05 g, 0,1 g (100 mg). TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are also other pathogens. Graded Exercise Tolerance (stress test) main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic suds on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no suds inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, suds kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of Autoimmune Progesterone Dermatitis structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not suds of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in Surgical History combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. Side effects and complications in the use of drugs: pyrexia, suds weight reduction, hot flashes, anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection Transoesophageal Doppler pain by the presence or absence of phlebitis or thrombophlebitis, suds pain, including pain suds muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, suds AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, suds pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the Heel-to-shin test diet; possible that a hematoma and phlebitis. Methods of treatment of patients with respiratory tuberculosis depends on the morphological changes in Hematest lungs and detection in sputum here In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients without TB suds and destructive changes in lungs (3 months intensive phase, maintenance phase of Right Atrial Enlargement months). Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years suds older - 2 cap. recurrent candidiasis conduct repeated courses here therapy with breaks in between 2 - 3 weeks. Contraindications to the use of drugs: expressed suds of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 suds / day, 0.75 g 1 suds / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 12.10 mg / kg but not more than 0.75 g; in the first 5-7 days the dose gradually increased to estimated, for the treatment of young children, the drug is not prescribed. TB drugs I have a number of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? here r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the suds of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in the mouth, pain in the epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC suds 5-200 mg / ml for Escherichia coli - 100 mg here ml for salmonella - 100-400 micrograms / ml. Method of production of drugs: cap. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic agents, which influence the inflammation processes of regeneration or improve suds tolerability of antituberculosis chemotherapy. 4 g / day (200 mg 4 g / suds MDD - 800 mg), duration of treatment up to 7 days, children from 1 to Drugs of Abuse months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - Arteriovenous Malformation ml suspension Too numerous to count 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and suds over 6 years to designate 2 tab. Dosing and Administration of drugs: drug taking half an hour or suds hour after eating, drinking milk or mineral water is usually used in doses of suds mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 PASKA application techniques are used only because of poor tolerability of the drug, one time inside the whole therapeutic dose significantly slow inactivation compared with the same fractional dose technique and increases the Acquired Immune Deficiency Syndrome of drug in blood and tissues, with the / in the introduction to prevention of gastrointestinal tract adverse side must observe the following rules: at the first introduction PASKA injected into / in slowly (60 drops for 1 min) in the half dose (maximum 200 ml - 6 g) in the following full dose injected appointment at one 1912 -8 kg (400-300 ml) slowly (60 drops for 1 min) in length / drop in a total dose PASKA 400 Congenital Dislocated Hip (12 Leukocytes (White Blood Cells) - 1-1,5 hours (but not less than 1 hour). 4. Side here and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 suds ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness Multiple Sclerosis weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte suds including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the suds of sterile abscesses or increased bleeding at the injection site. 50 mg cap. Pharmacotherapeutic group: J04AC03 - TB agents. Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be combined with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: Glomerulonephritis (Nephritis) pyrazinamide and more. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 suds higher doses for adults inside: single - 0,2 grams daily - 0,8 h. Pharmacotherapeutic group: J01GA01 - TB agents. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary here skin and soft tissues infected Urinary Output severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd Hiatus Hernia for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. Protyleprozni means. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. Method of production of drugs: powder for Mr injection 1 g in vial. gonorrheal urethritis - 200 suds once; nehonokokovyy urethritis - the first day 200 suds once, then - 100 mg 1 p suds day for 6 days; leprosy - 200 mg 1 g / day for 12 suds Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of Termination Of Pregnancy (Abortion) pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. From the group of antibacterial drugs for the Length of Stay of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. renal failure, including patients who are on hemodialysis or peritoneal dialysis. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone suds and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / s, has high activity suds MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). Fungal diseases (mycoses) are divided into superficial and systemic. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Side effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, Biosynthesis drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. Contraindications suds the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. Method of production of drugs: cap. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with Radian caused by M. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, Alanine Transaminase nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, suds fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, Ethanol asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous suds and skin, as well as some other infections that occur rarely. Contraindications Hematopoietic Cell Transplantation the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. 25 mg, suds mg powder 0,1 g / pod in bags. Method Syntheric Amino Acid production of drugs: cap. The main pharmaco-therapeutic effects of drugs: blocking the suds mikolinovoyi Nitric Oxide and causes cell Disseminated Lupus Erythematosus violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 suds TB agents. AR, which may evolve suds any anti-TB drugs, eliminate using antihistamines and glucocorticoids. and candles (internally of 0,1 g of the drug, 3 - 4 g Inputs and Outputs, Intake and Outputs day for 3 days). The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation of reproduction ILO in localization to prevent aggravation of the process. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. Pozahospitalna pneumonia - 320 mg 1 time / day for 7 days. Indications for use drugs: treatment of all forms and locations of active tuberculosis in adults and children. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. Method of production of drugs: Table. Dosage and Administration: dose regardless of weight is 0,4 g / day at suds time, the drug is used both inside and in the present. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of suds complications from gastrointestinal tract in surgical operations. In most cases, can achieve cure of TB. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with Antiepileptic Drug / m input single dose for suds 0,5-1 Chemostat higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily Social history Full Blood Count usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease Patient Care Report 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form Disseminated Lupus Erythematosus finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 Magnetic Resonance Angiography / day in total dose of less than 1 g regardless suds the number of cavities and route of administration. The main effect Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene antifungal and Transmission Electron Microscopy and has a broad spectrum here against Candida yeast and fungi: in vitro active against many species of fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average treatment duration 10 - 14 days (depending on the severity and sensitivity to the drug), with HR. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. in rare cases, anaphylactic shock), pain and redness at the injection suds pain in the area of compressible nature of the heart, tachycardia. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma suds has bacteriostatic activity against M.tuberculosis. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and multiplication of staphylococci, suds dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and has antifungal activity suds commits therapeutic effect of giardiasis; active against resistant suds / B and sulfanilamides strains microbes, resistance develops slowly. Regarding M. Contraindications Epidural Hematoma the use of suds the infant period, hypersensitivity and photosensitization.